Farmakodynamiske analyser påviste, at dette var en midlertidig virkning; restitution af normale B- celler begyndte inden for 6 måneder, og gennemsnitsantallet af B- celler var inden for normalområdet inden for 9 måneder efter behandlingen.
Pharmacodynamic analysis demonstrated that this was a temporary effect; recovery of normal B-cells began within 6 months and median counts of B-cells were within normal range within 9 months after treatment.